Vivolight Medical Highlights OCT-Guided Bifurcation Intervention and Previews Cold Laser Research at TCT 2026

San Diego, California — November 1, 2026 — Transcatheter Cardiovascular Therapeutics (TCT) 2026 is underway at the San Diego Convention Center, bringing together interventional cardiologists, researchers, and medical technology innovators from around the world.

Returning to TCT for the second consecutive year, Vivolight Medical is highlighting developments in intravascular optical coherence tomography (OCT) and 355-nm cold laser atherectomy (CLA), connecting clinical applications of advanced imaging with emerging research in laser-based coronary intervention.

Among the scientific highlights of October 31 was a clinical case shared by Dr. Lam Lap Tin's team from Hong Kong, exploring the role of OCT in complex coronary bifurcation stenting.

Clinical Insights: OCT in Complex Bifurcation Stenting

On October 31, Dr. Lam Lap Tin's team from Hong Kong shared a clinical case entitled "A Case of Utilizing OCT in Bifurcation Stenting – Procedural Planning and Bail-out" (TCT 1729) during the CHIP: Imaging-Guided Bifurcation Techniques session.

Complex coronary bifurcation lesions present significant procedural challenges, requiring careful assessment of vessel anatomy, appropriate stenting strategies, and timely decision-making when complications arise.

Intravascular OCT provides high-resolution cross-sectional visualization of coronary arteries, complementing angiography with detailed information about vessel morphology and stent-related characteristics.

The clinical case focused on the application of OCT in procedural planning and bail-out decision-making during complex bifurcation intervention, reflecting the importance of intravascular imaging in contemporary percutaneous coronary intervention (PCI).

The clinical themes explored in the presentation underscore the value of integrating detailed anatomical imaging into interventional strategies, particularly when managing challenging coronary lesions.

Cornaris P80-E: Bringing Advanced OCT Imaging into Clinical Practice

The focus on OCT-guided coronary intervention aligns closely with Vivolight Medical's continued development of intravascular imaging technologies.

The company's flagship Cornaris P80-E Intravascular Imaging System, which received U.S. FDA 510(k) clearance in April 2025, provides high-resolution cross-sectional imaging to support coronary lesion assessment, procedural planning, and post-intervention evaluation.

Through detailed visualization of coronary anatomy and stent deployment, Cornaris P80-E is designed to provide physicians with additional imaging information during PCI.

At Booth 3321, Vivolight Medical is showcasing Cornaris P80-E during the TCT exhibition, welcoming physicians and industry professionals to explore its imaging capabilities and discuss clinical applications.

Looking Ahead: 355-nm Cold Laser Atherectomy Research

Alongside its OCT developments, Vivolight Medical is highlighting upcoming clinical research investigating 355-nm cold laser atherectomy for complex coronary lesions.

On November 1 at 5:00 PM PST, Dr. Chenguang Li from Zhongshan Hospital, Fudan University, is scheduled to present Scientific Abstract TCT 1531 at Station 7.

The study, entitled "355-nm Cold Laser Atherectomy versus Excimer Laser for Complex Coronary Lesions: A Prospective, Multicenter, Randomized Non-inferiority Trial," evaluates 355-nm cold laser atherectomy against conventional 308-nm excimer laser coronary atherectomy.

The research investigates the safety and efficacy of this emerging approach to lesion preparation in challenging coronary interventions. The upcoming scientific presentation is expected to contribute additional clinical evidence to the ongoing development of cold laser technology for coronary intervention.

Advancing Innovation Through Clinical Collaboration

From OCT-guided coronary intervention to ongoing research in cold laser atherectomy, Vivolight Medical continues to advance laser-based technologies for minimally invasive cardiovascular diagnosis and treatment.

Through engineering innovation, clinical research, and international collaboration, the company remains committed to developing medical solutions that respond to evolving clinical needs and support better patient care worldwide.

Visit Vivolight Medical at Booth 3321

San Diego Convention Center